Italy's Recordati Takes Slice of French OTC Market With Laboratoires Tonipharm
Executive Summary
Recordati's new private-equity owners make their first move to strengthen the Italian firm's position in Europe's OTC market by grabbing Paris-based Laboratoires Tonipharm and its leading Ginkor brand.
You may also be interested in...
Recordati’s OTC Sales Lifted by Acquisitions And Italy
Italy's Recordati enjoyed strong growth in its home market and abroad, lifting OTC group sales in 2019.
Recordati to keep OTC following CVC buyout
Recordati insists that OTC will remain a “core” part of its business following the sale of a majority stake in the company to a consortium of private-equity funds led by CVC.
Recordati grows at home with Natural Point deal
Recordati has expanded its consumer healthcare portfolio by acquiring for an undisclosed sum Italian vitamins, minerals and supplements (VMS) specialist Natural Point.